Company Overview and News

2
Commodities Corner: Uranium market brightens as output cutbacks tighten supplies

2018-09-07 marketwatch
The suspension of operations at the world’s largest uranium mine in February and major output cutbacks from the biggest national producer have sparked a recovery in the market for the radioactive metal.
UEC EFR CCJ URG UUUU URE

2
Anfield Announces Uranium Resource Estimate for the Charlie Project

2018-09-05 globenewswire
VANCOUVER, British Columbia, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or “the Company”) is pleased to announce that BRS Engineering, Inc. (“BRS”) has completed a resource estimate for the Charlie uranium project (the “Charlie Project”) located in the Pumpkin Buttes Uranium District in Johnson County, Wyoming. In March 2018, Anfield announced that it had entered into a transaction with Cotter Corporation to acquire this asset.
UEC CCOP EFR BKHU ANLDD UUUU BKH

57
Interview With Mike Alkin: 'The Uranium Sector Offers The Best Risk-Reward I Have Seen In My Investing Career'

2018-09-04 seekingalpha - 2
I interview Mike Alkin, a 20-year experienced hedge fund analyst who has a contrarian and deep value investing approach.
YLLXF U TSLA EFR URG UUUU URPTF TTM

2
Vanadium Miners News For The Month Of August 2018

2018-08-29 seekingalpha
Vanadium market news - Vanadium market expected to grow, fueled by strong steel and increasing energy storage demands.
AVL SRHYY GLCNF KRC PRPCF TON NMT CCC APPPF SYR EFR AEE RDRUY ATVVF UUUU AUEEF LGO APAFF LGORF AMVMF SYAAF RRSSF BSHVF CCCCF bmn

10
Canadian Indexes Unmoved by Saudi Backlash: 3 Stocks to Buy

2018-08-13 zacks - 3
Canada’s market indexes took a dip on Aug 8, following a report that Saudi Arabia has started to get rid of its Canadian assets since Aug 7. A diplomatic dispute over human rights triggered the action taken by Saudi Arabia. However, the recovery of the stock indexes since then doesn’t indicate a major impact on the Canadian markets.
FOX GOOS EFR LMHA UUUU ARREF ARG LMHB FOXA LM

19
Westwater Resources' (WWR) CEO Christopher Jones on Q2 2018 Results - Earnings Call Transcript

2018-08-09 seekingalpha
Thank you for standing-by. This is the conference operator. Welcome to the Westwater Resources Inc. Second Quarter 2018 Results and Business Update Conference Call. As a reminder, all participants are in listen-only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. [Operator Instructions].
ABGPF ALP EFR WWR UUUU

4
Energy Fuels Is Perfectly Positioned For A Turnaround But Also Has More Downside After Recent Runaway

2018-08-06 seekingalpha - 2
I like the chances for the 232 petition based on the President Trump's policies over the last few months.
EFR UUUU

2
Implied Volatility Surging for Hertz Global (HTZ) Stock Options

2018-08-06 zacks
Investors in Hertz Global Holdings, Inc. (HTZ - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 17, 2018 $11.00 Put had some of the highest implied volatility of all equity options today.
EFR UUUU BGSF FUN HRI HTZ

3
Post Holdings (POST) Jumps: Stock Rises 8%

2018-08-06 zacks
Post Holdings, Inc. (POST - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. The stock picked up sharply from the near-flat trend of $85.17 to $88.94 in the past one month time frame.
POST POSTZ POSTU POSHZ EFR PF UUUU BGSF FUN

2
Are Options Traders Betting on a Big Move in Yelp (YELP) Stock?

2018-08-06 zacks
Investors in Yelp Inc. (YELP - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 10, 2018 $37.00 Put had some of the highest implied volatility of all equity options today.
YELP EFR UUUU BGSF FUN

2
Cooper Tire (CTB) Beats Q2 Earnings and Revenue Estimates

2018-08-06 zacks
Cooper Tire (CTB - Free Report) just came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.85 per share a year ago. These figures are adjusted for non-recurring items.
EFR UUUU BGSF FUN

2
Why Earnings Season Could Be Great for Jazz Pharmaceuticals (JAZZ)

2018-08-06 zacks
Investors are always looking for stocks that are poised to beat at earnings season Jazz Pharmaceuticals plc (JAZZ - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
JAZZ EFR UUUU BGSF FUN

4
Henry Schein (HSIC) Beats Q2 Earnings and Revenue Estimates

2018-08-06 zacks
Henry Schein (HSIC - Free Report) just came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.88 per share a year ago. These figures are adjusted for non-recurring items.
EFR UUUU HSIC BGSF FUN

3
Is a Surprise Coming for AES Corp (AES) This Earnings Season?

2018-08-06 zacks
Investors are always looking for stocks that are poised to beat at earnings season and The AES Corporation (AES - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
EFR UUUU AES BGSF FUN

2
Aerojet Rocketdyne Holdings (AJRD): Moving Average Crossover Alert

2018-08-06 zacks
Aerojet Rocketdyne Holdings, Inc. (AJRD - Free Report) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front. Recently, the 50 Day Moving Average for AJRD broke out above the 200 Day Simple Moving Average, suggesting a short-term bullish trend.
AJRD EFR UUUU BGSF FUN

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to TSX:EFR / Energy Fuels Inc. on message board site Silicon Investor.

Research Frontiers (REFR) Research Frontiers (REFR) Research Frontiers (REFR) Befriend the Trend Trading Befriend the Trend Trading Befriend the Trend Trading
Research Frontiers, Inc. REFR Updates Research Frontiers, Inc. REFR Updates Research Frontiers, Inc. REFR Updates REFR madness: Asencio reports on Research Frontiers Inc REFR madness: Asencio reports on Research Frontiers Inc REFR madness: Asencio reports on Research Frontiers Inc
REFR SPD-Smart (TM) technology REFR SPD-Smart (TM) technology REFR SPD-Smart (TM) technology REFR- 2002 and Beyond REFR- 2002 and Beyond REFR- 2002 and Beyond
Befriend the Trend DAYTRADING Thread Befriend the Trend DAYTRADING Thread Befriend the Trend DAYTRADING Thread Research Frontiers Inc. - Moderated (REFR) Research Frontiers Inc. - Moderated (REFR) Research Frontiers Inc. - Moderated (REFR)
BEFRIEND THE TREND Short-term Options Trading Thread BEFRIEND THE TREND Short-term Options Trading Thread BEFRIEND THE TREND Short-term Options Trading Thread Tefron (TFR) Tefron (TFR) Tefron (TFR)